Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Your own cells, reborn: a new hope for Parkinson's?

NCT ID NCT06344026

First seen May 17, 2026 · Last updated May 22, 2026 · Updated 2 times

Summary

This early-stage study tests the safety of a new treatment called ANPD001 for people with Parkinson disease. The treatment uses a person's own skin cells to create new dopamine-producing cells, which are then injected into the brain. The goal is to see if this approach is safe and tolerable for 9 participants aged 40-75.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Emory University

    Atlanta, Georgia, 30322, United States

  • Feinstein Institutes

    Manhasset, New York, 11030, United States

  • Scripps Health

    La Jolla, California, 92037, United States

  • University of Arizona - Banner Health

    Tucson, Arizona, 85724, United States

  • University of California, Irvine

    Orange, California, 92868, United States

  • University of California, Los Angeles

    Los Angeles, California, 90095, United States

  • University of California, San Diego

    San Diego, California, 92037, United States

  • University of California, San Francisco

    San Francisco, California, 94143, United States

  • University of Colorado

    Aurora, Colorado, 80045, United States

Conditions

Explore the condition pages connected to this study.